ReviewArchives of medical research2020

A Perspective on Erythropoietin as a Potential Adjuvant Therapy for Acute Lung Injury/Acute Respiratory Distress Syndrome in Patients with COVID-19.

Adeleh Sahebnasagh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.